MLAB News Alert Mesa Laboratories (MLAB) 73.79 02/14/2015 06

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mesa Laboratories (MLAB) 73.79 $MLAB

Mesa Labs Reports Record Third Quarter Revenues and Net Income
GlobeNewswire - Mon Feb 02, 9:05AM CST
Mesa Laboratories, Inc. (Nasdaq:MLAB) (we, us, our, "Mesa" or the "Company" today reported record revenues and net income for the third quarter ended December 31, 2014.
MLAB: 73.79 (-1.37)

Mesa Labs ups earnings 41% in FQ3
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 7:28AM CST

MLAB: 73.79 (-1.37)

Mesa Laboratories beats by $0.14
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 7:08AM CST

MLAB: 73.79 (-1.37)

Mesa Labs' board to pay USD0.16 per share dividend
M2 - Thu Jan 08, 4:58AM CST
The board of directors of Mesa Laboratories (NasdaqGS:MLAB), a healthcare products company, on Wednesday declared its quarterly dividend of USD0.16 per share of its common stock.
MLAB: 73.79 (-1.37)

11 Dividend Achievers With Strong Buy Rating
Dividend Yield - Seeking Alpha - Wed Jan 07, 7:57AM CST
Are you looking for stocks that are worth buying? Sure, we all do! Today, I'd like to show you some of the stocks with the highest buy rating within the Dividend Growth space. I've compiled all Dividend Achievers, stocks that have raised dividends...
BTI: 111.13 (-1.46), ACU: 18.70 (unch), JJSF: 100.08 (-0.44), HDB: 58.41 (-0.98), AFSI: 55.60 (-0.89), HWKN: 38.57 (-0.20), EBMT: 11.05 (+0.05), RAVN: 21.95 (+0.17), MLAB: 73.79 (-1.37), UTMD: 58.02 (-0.40), VGR: 22.52 (-0.26)

Mesa Laboratories declares $0.16 dividend
Seeking Alpha - at Seeking Alpha - Tue Jan 06, 5:02PM CST

MLAB: 73.79 (-1.37)

Mesa Labs Declares Quarterly Dividend
GlobeNewswire - Tue Jan 06, 5:00PM CST
Mesa Laboratories, Inc. (Nasdaq:MLAB) (we, us, our, "Mesa" or the "Company" today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 16, 2015, to shareholders of record at the close of business on February 27, 2015.
MLAB: 73.79 (-1.37)

Nasdaq stocks posting largest percentage decreases
AP - Tue Dec 30, 12:24PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
LOXO: 11.91 (-0.24), IMDZ: 25.34 (+1.20), AMTX: 4.52 (+0.13), CTSO: 8.20 (+0.18), MARPS: 11.70 (+0.10), JST: 5.35 (+0.14), GTWN: 17.55 (-0.40), MLAB: 73.79 (-1.37)

How it All Plays Out -- Analyst Notes on Magnetek, Malibu Boats, Matthews, Mercury and Mesa
PR Newswire - Wed Dec 17, 6:40AM CST
Moments ago, Realtime Equities released new analyst updates concerning several important developing situations including Magnetek (NASDAQ: MAG), Malibu Boats (NASDAQ: MBUU), Matthews (NASDAQ: MATW), Mercury (NASDAQ: MRCY), and Mesa (NASDAQ: MLAB). Realtime Equities is the leader in realtime news, commentary and analysis - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
MAG: 40.68 (-0.20), MATW: 49.13 (+0.73), MLAB: 73.79 (-1.37), MBUU: 20.04 (+0.15), MRCY: 17.42 (-0.17)

Dividend Contenders, Future Champions Or Future Failures: Part 9
Stan Stafford - at Seeking Alpha - Thu Dec 11, 8:26PM CST

WST: 51.35 (+0.57), ATRI: 332.77 (-2.85), MLAB: 73.79 (-1.37)

Shares of MLAB Up 15.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Nov 17, 6:03PM CST
SmarTrend identified an Uptrend for Mesa Laboratories (NASDAQ:MLAB) on October 16th, 2014 at $67.85. In approximately 1 month, Mesa Laboratories has returned 15.93% as of today's recent price of $78.66.
MLAB: 73.79 (-1.37)

Mesa Laboratories Shares Up 21.6% Since SmarTrend's Buy Recommendation (MLAB)
Comtex SmarTrend(R) - Mon Nov 10, 12:40PM CST
SmarTrend identified an Uptrend for Mesa Laboratories (NASDAQ:MLAB) on October 16th, 2014 at $67.85. In approximately 4 weeks, Mesa Laboratories has returned 21.59% as of today's recent price of $82.50.
MLAB: 73.79 (-1.37)

Mesa Labs ups earnings 63% in FQ2
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 10:03AM CST

MLAB: 73.79 (-1.37)

Mesa Laboratories Shares Up 13.3% Since SmarTrend's Buy Recommendation (MLAB)
Comtex SmarTrend(R) - Mon Nov 03, 10:03AM CST
SmarTrend identified an Uptrend for Mesa Laboratories (NASDAQ:MLAB) on October 16th, 2014 at $67.85. In approximately 3 weeks, Mesa Laboratories has returned 13.26% as of today's recent price of $76.85.
MLAB: 73.79 (-1.37)

Mesa Labs Reports Record Second Quarter Revenues and Net Income
GlobeNewswire - Mon Nov 03, 7:37AM CST
Mesa Laboratories, Inc. (Nasdaq:MLAB) (we, us, our, "Mesa" or the "Company" today reported record revenues and net income for the second quarter ended September 30, 2014.
MLAB: 73.79 (-1.37)

Mesa Laboratories EPS of $1.04
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 7:08AM CST

MLAB: 73.79 (-1.37)

Mesa Labs acquires ATI Atlas' assets in Europe for undisclosed amount
M2 - Mon Nov 03, 5:40AM CST
Healthcare company Mesa Laboratories (NasdaqGS:MLAB) revealed on Friday the completion of the acquisition of substantially all of the assets and certain liabilities of ATI Atlas through its French subsidiary, Amilabo SAS.
MLAB: 73.79 (-1.37)

Mesa Labs Acquires Its UK and Irish Republic Distributor of Biological Indicators
GlobeNewswire - Fri Oct 31, 12:16PM CDT
Mesa Laboratories, Inc. (Nasdaq:MLAB) (we, us, our, "Mesa" or the "Company" today announced the acquisition of substantially all of the assets and certain liabilities of ATI Atlas Limited, ("ATI" by Amilabo SAS ("Amilabo" , the Company's subsidiary located near Lyon, France. ATI, located near London, is a distributor of the Company's biological indicator ("BI" products in the UK.
MLAB: 73.79 (-1.37)

Mesa acquires process challenge business
Seeking Alpha - at Seeking Alpha - Wed Oct 15, 3:11PM CDT

MLAB: 73.79 (-1.37)

Mesa Labs Acquires a Process Challenge Device Business
GlobeNewswire - Wed Oct 15, 1:07PM CDT
Mesa Laboratories, Inc. (Nasdaq:MLAB) (we, us, our, "Mesa" or the "Company" today announced the acquisition of substantially all of the assets and certain liabilities of the process challenge device business (the "PCD Business" from PCD - Process Challenge Devices, LLC, a California company ("PCD-LLC" .
MLAB: 73.79 (-1.37)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lauletta Birnbaum Earns Distinction in 2026 Chambers Guide

Updated Category News Views 209

Lauletta Birnbaum Recognized in the 2026 Chambers Spotlight Guide Lauletta Birnbaum has received prestigious recognition in the 2026 Chambers Spotlight Guide in the category of Corporate/Commercial Law. This honor highlights the firm's commitment to providing exceptional legal services to its clients. The Importance of Legal Recognition Chambers and Partners is recognized...

Continue Reading
Medicenna Therapeutics Showcases Advances in Cancer Treatment

Updated Category News Views 127

Medicenna Therapeutics Showcases Advances in Cancer Treatment Medicenna Therapeutics Corp. is making notable strides in the field of cancer immunotherapy. With a focus on developing innovative therapies, the company is gaining attention for its promising Superkines targeting a range of conditions, including cancer. One of their leading programs, MDNA11, has showcased...

Continue Reading
DÉKUPLE Reports Strong Growth in First-Half Earnings 2024

Updated Category News Views 258

DÉKUPLE reported its first-half earnings for 2024, showcasing an 8.8% rise in net sales, totaling €104.6 million. The figures signal a resilient company navigating a turbulent economic backdrop, but traders are already weighing the potential fallout. Key Financial Metrics: Profitability vs. Economic Headwinds The group's gross margin jumped 5.8%, hitting €83.5...

Continue Reading
Main Street Capital Corporation Declares 2025 Dividend Increases

Updated Category News Views 220

Regular Monthly Dividends Announced by Main Street Capital Main Street Capital Corporation (NYSE: MAIN) has taken a significant step forward in announcing its regular monthly dividends for the early part of 2025. The Board of Directors has declared a monthly dividend of $0.25 per share for January, February, and March of that year. This move showcases the company's...

Continue Reading
Exciting New Travel Offers Just for Travelzoo Club Members

Updated Category News Views 306

Exclusive Travel Offers for Club Members Travelzoo® (NASDAQ: TZOO), a leading platform for travel enthusiasts, has rolled out an enticing set of offers tailored specifically for its Club Members. These deals are meticulously negotiated to provide the best experiences at the most competitive prices. Whether you're looking for adventure or relaxation, there's something for...

Continue Reading